Hypertension Canada is the only national non-profit organization dedicated solely to the prevention and control of hypertension and its complications. Select from the following links to learn more about our:
We work with leading minds across medical and health disciplines to advance research and professional and public education, and with policy makers to ensure Canadians can avoid the potentially deadly complications of hypertension.
Seven and a half million people in Canada, about 1 in 5 adults, live with hypertension. Rising blood pressure over the long term causes atherosclerosis – the main risk for premature death (before the age of 65).
Canada has become a leader in the early detection of high blood pressure, its treatment and overall management. Much of this success has been attributed to the Hypertension Canada Guidelines – a set of clinical practice guidelines which are rigorously reviewed and updated annually, providing health care professionals with the most up-to-date recommendations and guidelines for the detection, treatment and control of hypertension.
Despite recent achievements, 1 in 3 people with hypertension has uncontrolled blood pressure, particularly high-risk patients with diabetes and kidney disease; and almost 1 in 5 people with hypertension is unaware of their condition.
Mission & Vision
Advancing health through the prevention and control of high blood pressure and its complications.
Canadians will have the healthiest and best-managed blood pressure in the world.
Hypertension Canada delivers against mission/vision by striving for excellence in three core service areas:
- Research: knowledge generation through research and innovation.
- Education: knowledge translation by turning discovery into practice.
- Advocacy: Creating supportive environments through healthy public policy and lifestyles.
Charitable Registration Number: 897016275RR0001
Board of Directors:
President and Chair of the Board
Vancouver, British Columbia
Dr. Nadia Khan is an Associate Professor of Medicine in the Division of General Internal Medicine at the University of British Columbia, a scientist at the Center for Health Evaluation and Outcomes Sciences (CHEOS), and a general internist at St. Paul’s Hospital in Vancouver. Dr. Khan was elected to Hypertension Canada’s Board in 2013.
Dr. Khan was a member of the Central Review Committee for the Canadian Hypertension Education Program (CHEP) from 2002 to 2013, and is Chair of Hypertension Canada’s Research Policy Committee.
Dr. Khan has been conducting research on hypertension epidemiology and gender and ethnic differences in cardiovascular disease and risk factors. She is currently funded to investigate chronic cardiovascular disease management in ethnic groups by a Career Scientist award from the Michael Smith Foundation for Health Research.
Dr. Ross Tsuyuki is Professor and Chair, Department of Pharmacology in the Faculty of Medicine and Dentistry, University of Alberta. He is also a Professor of Medicine (Cardiology) and Director of EPICORE Centre (a health research coordinating centre) and the Editor-in-Chief of the Canadian Pharmacists Journal. His clinical practice is in the Heart Function Clinic at the Mazankowski Alberta Heart Institute. Having previously served on Hypertension Canada’s Board of Directors, Dr. Tsuyuki was elected in 2019 and appointed Vice-President. He also serves as a Co-Chair of the Education & Implementation Committee and is a member of the Hypertension Canada Guidelines Committee.
Dr. Tsuyuki’s interests are in clinical trials design and execution, hypertension, heart failure, community practice-based research, cardiovascular risk factors, and in the provision of support for clinical researchers through the EPICORE Centre. Dr. Tsuyuki has received several awards for teaching, as well as an appointment as a Fellow of the Canadian Society of Hospital Pharmacists, the American College of Cardiology and the Canadian Academy of Health Sciences. In 2005, he was recognized as the Canadian Pharmacist of the Year by the Canadian Pharmacists Association.Mr. Glen Doucet is the Vice President, Advocacy and Public Affairs at the Canadian Pharmacists Association and has over 20 years’ expertise in government relations, policy development, strategic communications, and governmental regulatory processes. Mr. Doucet was elected to Hypertension Canada’s Board in 2014.
Mr. Trevor Hudson is a senior manager in the Business Tax Services group with Deloitte and is focused primarily on the P3 infrastructure and the alternative energy sectors. Mr. Hudson was elected to Hypertension Canada’s Board in 2014.
Mr. Hudson has more than 14 years of professional experience in public practice with Deloitte and focuses primarily on the P3 infrastructure and the alternative and renewable energy sectors providing tax advisory services to Canadian and foreign based clients on matters relating to general tax planning, corporate reorganizations, mergers and acquisitions, tax accounting, and tax compliance reporting. Previously, Mr. Hudson worked in Deloitte’s assurance and advisory practice providing audit and accounting services to large public multinational clients as well as small medium and large private companies across a range of industries, including manufacturing, oil and gas, financial services, and not-for-profits. Mr. Hudson is the chair of Deloitte’s United Way employee campaign.
In addition to working in public practice, Mr. Hudson has also worked in the capital markets group of a large Canadian bank as well as for a large Canadian pension fund.
Mr. Hudson is a Chartered Professional Accountant and holds a Master of Business Administration degree, a Master of Tax degree, and a Bachelor of Science Degree in Biochemistry.
Mr. Hudson lives in Oakville, Ontario with his lovely wife and daughter and is an avid runner and hockey player.
Dr. Bell is a family physician and clinical researcher in Toronto, Canada. He is Assistant Professor in the Department of Family and Community Medicine, University of Toronto and on the active staff of the Humber River Regional Hospital. He is a recipient of the Canadian College of Family Physicians Award of Excellence. His activities include:
- Past Chair – Canadian Cardiovascular Society Antiplatelet Guideline Committee
- Thrombosis Canada – Executive Council
- Canadian Stroke Network Professional Development Committee
- Canadian Medical Association Journal – Peer Reviewer
Dr. Bell’s involvement in continuing medical education includes the development and presentation of many national projects. He has served as faculty and chair of countless committees and advisory boards dedicated to serving the common interests of the medical profession and the public. His research, commentaries and letters have been presented and published internationally.
Mr. Glen Doucet is the Vice President, Advocacy and Public Affairs at the Canadian Pharmacists Association and has over 20 years’ expertise in government relations, policy development, strategic communications, and governmental regulatory processes. Mr. Doucet was elected to Hypertension Canada’s Board in 2014.
Mr. Doucet has served as a member of the senior management teams for the Canadian Medical Association and for the Canadian Diabetes Association where he led expansive advocacy campaigns that measurably improved patient access and outcomes in every province.
Mr. Doucet also has a passion for public service and politics. He has served as the National Director and Director of Policy for a major federal political party and in senior roles for leadership campaigns for two of the three leading federal political parties. He currently serves on the Board of the Canadian Skin Cancer Foundation.
Keeping Mr. Doucet grounded are his wife Dalaila, his ongoing pursuit to break eighty on the golf course and his pet goldfish Pilot.
Dr. Robert Gros, elected 2019, is currently a scientist at the Robarts Research Institute and an associate professor in the Departments of Physiology and Pharmacology and of Medicine at Western University in London, Ontario. He completed his training at Western University and fellowship training at the Toronto General Hospital. He is Director of the Canada Foundation for Innovation-funded Laboratory for Cardiovascular and Metabolic Phenotyping of Genetically-modified mice. He serves as a committee member on national granting agency review panels and holds leadership roles on the Scientific Program Committees for both the Ontario Hypertension Society and Hypertension Canada. Dr. Gros served as Co-Chair of the Canadian Hypertension Congress since its inaugural event and is a Senior Mentor of the Young Investigator Forum.
The focus of Dr. Gros’ research programme is to investigate the cellular/ molecular mechanisms involved in the regulation of vascular and cardiac function. He has a particular interest in the role and regulation of G protein-coupled receptor signaling pathways as well as the role of both the neuronal and non-neuronal cholinergic system and their contribution under physiological and pathological conditions such as hypertension and heart failure.
Dr. Swapnil Hiremath, elected 2019, is a Staff Nephrologist at the Ottawa Hospital, an Associate Professor in the Faculty of Medicine at the University of Ottawa, and an Associate Scientist in the Clinical Epidemiology Programme at the Ottawa Hospital Research Institute. With his medical education at the University of Mumbai and at the University of Ottawa, Dr. Hiremath holds a Masters in Public Health from the Harvard School of Public Health and certification from the American Society of Hypertension as a Specialist in Hypertension. Dr. Hiremath is a member of the Hypertension Canada Guidelines Committee and the Blood Pressure Measurement Device Recommendations Program Expert Committee.
Dr. Hiremath’s primary research interest is in using systematic reviews, meta-analyses and decision-analytic modeling to improve care for patients with hypertension, chronic kidney disease, hemodialysis and patients with acute kidney injury. He has over $5 million research grant funding from the Canadian Institutes of Health Research, Physicians Services Incorporated, the Ottawa Hospital Academic Medical Organization, and other agencies, in the area of contrast AKI and difficult to control hypertension. He has authored more than 100 papers and is the co-creator of the open, online twitter-based nephrology journal club, #NephJC.
Dr. Janusz Kaczorowski is Professor and Research Director in the Department of Family and Emergency Medicine at the Université de Montréal. Dr. Kaczorowski was elected to Hypertension Canada’s Board in 2013.
Dr. Kaczorowski is a holder of the Dr. Sadok Besrour Chair in Family Medicine and the GlaxoSmithKline-Canadian Institutes of Health Research (CIHR) chair in Optimal Management of Chronic Disease. He directs the Evaluation, Health Care Systems and Services research theme at the Université de Montréal Hospital Research Centre (CRCHUM). He plays leadership roles in the hypertension, stroke and primary care research communities in Canada. He has an active, collaborative and multi-disciplinary research agenda that includes optimal use of therapeutics in primary care, primary prevention of cardiovascular disease and stroke, knowledge transfer, health services research and population health.
Dr. Kaczorowski has over 20 years’ experience in developing, coordinating, and completing all aspects of research studies in primary care. He has held a number of large grants both as principal investigator and co-investigator and has co-authored over 200 peer-reviewed articles.
David Lui is the Vice President of Marketing for Mark’s at Canadian Tire Corporation and has over 25 years’ experience in the retail industry. As an industry thought leader and member of the Retail Leadership Committee for the Canadian Marketing Association, he is passionate about the ever-changing retail market, supporting the needs of marketers, and has been recognized through multiple business awards for his excellence in the field.
David currently leads a team of marketing professionals to expand Mark’s identity through the development and implementation of innovative brand and marketing strategies. Over the course of his career, he has held senior executive roles with Global Apparel and Consumer Goods Brands, including Nygård, The North West Company, The Daiso and Esprit. In addition to his experience with these multinational corporations, he has dedicated his time to support non-profit organizations such as United Way Winnipeg, Take Pride Winnipeg!, Habitat For Humanity, Canadian Tire Jumpstart and the Canadian Diabetes Association.
As an avid competitive athlete, David has participated in destination marathons and competitive cycling events. David holds an MBA from the Ivey Business School at Western University.
Victoria, British Columbia
Ms. Dorothy Morris is a clinical nurse educator in cardiac surgery and coronary care at the Royal Jubilee Hospital, Victoria, British Columbia and Canadian Council of Cardiovascular Nurses (CCCN)’s National director for health promotion and advocacy. Ms. Morris was elected to Hypertension Canada’s Board in 2014.
Ms. Morris has co-authored and teaches a basic arrhythmia interpretation and management course, speaks on a variety of cardiovascular topics and has published a number of articles.
She has given numerous presentations at national and international conferences including the Canadian Association of Gerontology, The International Society of Hypertension and the Canadian Cardiovascular Congress. She contributes to the work of Hypertension Canada and the Canadian Institutes of Health Research / Heart and Stroke Foundation Chair’s Hypertension Advisory Committee.
In 2005, Ms. Morris received the award of excellence for nursing education from the college of registered nurses of British Columbia and the clinical cardiovascular excellence award from CCCN. She has also been the recipient of an award of excellence from Hypertension Canada and award of merit for workplace health innovation from the health employers association of British Columbia.
Ms. Morris has a keen interest in cardiovascular disease risk factors, health advocacy and in continuing nursing education initiatives.
Dr. Raj Padwal is a physician, epidemiologist and health services researcher, with expertise in clinical pharmacology, general internal medicine and clinical epidemiology. He is presently a full Professor in the Division of Internal Medicine at the University of Alberta.
Raj received his medical degree in 1995 from the University of Saskatchewan. He completed his Internal Medicine training at the University of Alberta before a research fellowship in Clinical Pharmacology at the University of Toronto, where he also earned his Master of Science in Clinical Epidemiology. As an academic internist and a health services researcher with an interest in cardiovascular risk management, his specific areas of interest include hypertension, blood pressure measurement and bariatric (obesity) care. He has published 143 peer-reviewed papers and 10 book chapters.
Raj has been actively engaged in Hypertension Canada and its heritage organizations since 2004, when he first joined the the CHEP Recommendations Task Force of which is now Co-Chair. He serves also as a member of the CHEP Central Review Committee, and of Hypertension Canada’s Operations Committee. Among his many professional awards, he received Hypertension Canada’s Senior Investigator Award in 2014.
Chief Executive Officer
Angelique Berg is a business development and marketing executive with over 20 years’ experience spanning both profit and non-profit health sectors. Her leadership experience includes roles in public and government relations, program and volunteer management, and over 15 years in fundraising.
Angelique has held executive positions in the charitable health sector, including Osteoporosis Canada, the Canadian Diabetes Association, and the Canadian Orthopaedic Foundation. She has served on health sector collaborations that accelerated health care system and patient care improvements, including the Wait Times Alliance, the Alliance for the Canadian Arthritis Program, and the Bone and Joint Decade Canada. An active ambassador for the sector, she has served as a Steering Committee member of the Health Charities Coalition of Canada, and is a member of the Association of Fundraising Professionals and the Canadian Society for Association Executives. Angelique volunteers with the Canadian Orthopaedic Association, as well as with personal interest causes, including Halton Region’s Project Autism, and a WWII RCAF veterans’ association.
Angelique is a strategic, collaborative leader with a proven track record of achieving revenue targets through creating high performance teams. She is known for her dedication to excellence in charitable management, and for her passion to improve health for a thriving, productive society.
Our Impact 2019
We measure our performance by our impact. Click here to view our 2019 Annual Report.
Hypertension Canada Awards
The annual awards recognize a distinguished record of substantial contributions by individual or organizations that have increased prevention and/or improved control of blood pressure in Canada. Deadline for nominations – May 15, 2020
Hypertension Innovations Award
The new annual award recognizes a member or organization that implements innovative approaches in knowledge translation and education related to hypertension and/or primary prevention.
- 2020 Call for Nominations for the Hypertension Innovations Award (.pdf)
- Download 2019 Hypertension Innovations Award Recipient (.pdf)
George Fodor Award
The George Fodor Award recognizes a distinguished record of substantial contributions by individuals or organizations that have increased prevention and/or improved control of blood pressure in Canada. Contributions worthy of this prestigious award are expected to be broad in scope (i.e., national) and enduring over time, and to have had a substantive impact.
- 2020 Call for Nominations for the George Fodor Award (.pdf)
- Download 2019 George Fodor Award Recipient (.pdf)
- Download 2017 George Fodor Award Recipient (.pdf)
- Download 2014 George Fodor Award Recipient (.pdf)
Distinguished Service Award
The Distinguished Service Award recognizes a long-standing distinguished record of service to Hypertension Canada by an individual. A nominee must have made significant voluntary service contributions to Hypertension Canada and prolonged contributions to the Canadian Hypertension Society, Blood Pressure Canada and/or Hypertension Canada Guidelines over their career.
- 2020 Call for Nominations for the Distinguished Service Award (.pdf)
- Download 2019 Distinguished Service Award Recipient (.pdf)
- Download 2017 Distinguished Service Award Recipient (.pdf)
- Download 2016 Distinguished Service Award Recipient (.pdf)
- Download 2015 Distinguished Service Award Recipient(.pdf)
- Download 2014 Distinguished Service Award Recipient (.pdf)
Senior Investigator Award
The Senior Investigator Award recognizes research in hypertension or blood pressure by an individual. A nominee must have made significant contributions to the advancement and extension of knowledge in basic, clinical, health services or population-based research specifically relating to hypertension or blood pressure.
- 2020 Call for Nominations for the Senior Investigator Award (.pdf)
- Download 2019 Senior Investigator Award Recipient (.pdf)
- Download 2017 Senior Investigator Award Recipient (.pdf)
- Download 2016 Senior Investigator Award Recipient (.pdf)
- Download 2015 Senior Investigator Award Recipient (.pdf)
- Download 2014 Senior Investigator Award Recipients (.pdf)
Jacques de Champlain New Investigator Award
The Jacques de Champlain New Investigator Award recognizes excellence in the field of hypertension or blood pressure research by a new investigator, who has not exceeded a time period of 10 years from the first appointment as an independent investigator. A nominee must have made significant contributions to the advancement and extension of knowledge in basic, clinical, health services or population-based research specifically relating to hypertension or blood pressure.
- 2020 Call for Nominations for the Jacques de Champlain New Investigator Award (.pdf)
- Download 2019 Jacques de Champlain New Investigator Award Recipient (.pdf)
- Download 2017 Jacques de Champlain New Investigator Award Recipient (.pdf)
- Download 2014 Jacques de Champlain New Investigator Award Recipient (.pdf)
Certificates of Excellence
Throughout Canada, community, provincial, regional or national initiatives and ongoing programs of high blood pressure prevention and control are instrumental in improving the control of blood pressure. Many of these initiatives are led and contributed to by community-based organizations, individuals and volunteer efforts. These activities are essential to the health of the average Canadian by potentially lowering cardiovascular disease, but are rarely acknowledged. The Certificates of Excellence are presented to these worthy individuals or organizations in recognition of their outstanding efforts and contributions in Canada through increased public awareness, prevention or control of hypertension.
- 2020 Call for Nominations for the Certificate of Excellence Award (.pdf)
- Download 2019 Certificate of Excellence Recipient (.pdf)
- Download 2017 Certificate of Excellence Recipients (.pdf)
- Download 2016 Certificate of Excellence Recipients (.pdf)
- Download 2015 Certificate of Excellence Recipients (.pdf)
- Download 2014 Certificate of Excellence Recipients (.pdf)
The Outstanding Volunteer Award
The Outstanding Volunteer Award is presented to worthy individuals in recognition of their outstanding efforts and contributions to move forward the mission and vision of Hypertension Canada.